MedGene Therapeutics, Inc. is a T cell immunotherapy company whose primary goal is the treatment of solid tumor cancers. T cells are the body’s major natural defense against the tumors.. By extracting a patient’s active T cells, replicating & enriching them, then reinfusing the cells back into the patient’s bloodstream, we can enhance the body’s defenses against cancer.
While T cell therapy has been available for over 30 years, scientists have been unable to achieve results with the treatment in solid tumors. We have licensed PBL-T from NIH, and developed RIV-8 as a collaboration with Seoul National University. These drugs are the result of years of development, and are the fundamental platform technologies for for MedGene Therapeutics.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 9841 Washingtonian Blvd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.medgenetx.com/
- Keywords
- Brookings.
- HQ
- Gaithersburg, Maryland
Medgene Therapeutics, Inc. Questions
Medgene Therapeutics, Inc.'s website is https://www.medgenetx.com/
Medgene Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/medgenetx
Medgene Therapeutics, Inc. has
2 employees.
View email and phone details for 2
employees at Medgene Therapeutics, Inc..
Medgene Therapeutics, Inc.'s industry is
Biotechnology Research
Medgene Therapeutics, Inc.'s top competitors are
Nextcure, Inc.,
Gegadyne Energy,
Nkilt Therapeutics, Inc.,
Medgini,
Tinyowl,
Medgene,
Orgenesis Inc.,
Us Medigene,
Sparingvision,
Keystone Lifesci Collaborative.
Medgene Therapeutics, Inc.'s categories are Biotechnology Research
Medgene Therapeutics, Inc.'s founding year is 2015
